CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- S-3 Offering Registration Statement
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement · Other events
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Gift Director gave 9,542 shares (gift)
- ARS Other Annual Report to Security Holders
- 4 Open-market sale Director sold 10,000 shares at an average $28.03 ($280,281)
- DEF 14A Proxy Proxy Statement
- D Other Notice of Sales of Unregistered Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
Page 4 of 13 · 259 filings